Detalles de la búsqueda
1.
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer.
Nature
; 603(7903): 942-948, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35322232
2.
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial.
Lancet
; 401(10389): 1655-1668, 2023 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37068504
3.
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial.
Lancet
; 402(10409): 1272-1281, 2023 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37708904
4.
A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus.
Future Oncol
; 19(11): 739-752, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36919706
5.
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
Lancet
; 398(10294): 27-40, 2021 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34102137
6.
Fluorescence Liquid Biopsy for Cancer Detection Is Improved by Using Cationic Dendronized Hyperbranched Polymer.
Int J Mol Sci
; 22(12)2021 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34204408
7.
Isolation of exosomes from whole blood by a new microfluidic device: proof of concept application in the diagnosis and monitoring of pancreatic cancer.
J Nanobiotechnology
; 18(1): 150, 2020 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33092584
8.
Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab.
Oncologist
; 23(9): 1092-1102, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29700210
9.
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study.
BMC Cancer
; 18(1): 1185, 2018 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30497432
10.
Desmoid-Type Fibromatosis: Who, When, and How to Treat.
Curr Treat Options Oncol
; 18(5): 29, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28439797
11.
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.
Lancet Oncol
; 17(10): 1386-1395, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27575023
12.
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
Br J Cancer
; 115(7): 789-96, 2016 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27599039
13.
TRAIL-coated lipid-nanoparticles overcome resistance to soluble recombinant TRAIL in non-small cell lung cancer cells.
Nanotechnology
; 27(18): 185101, 2016 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27001952
14.
Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease.
Int J Cancer
; 137(6): 1362-73, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25721731
15.
Nab-Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer.
NEJM Evid
; 3(2): EVIDoa2300144, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38320486
16.
Improving shared decision-making about cancer treatment through design-based data-driven decision-support tools and redesigning care paths: an overview of the 4D PICTURE project.
Palliat Care Soc Pract
; 18: 26323524231225249, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38352191
17.
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial.
J Clin Oncol
; : JCO2301601, 2024 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38382001
18.
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study.
J Clin Oncol
; : JCO2301636, 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38723227
19.
X-ray Photoelectron Spectroscopy (XPS) Analysis of Nitrogen Environment in Small Extracellular Vesicle Membranes: A Potential Novel Technique with Application for Cancer Screening.
Cancers (Basel)
; 15(9)2023 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37173946
20.
Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649.
J Clin Oncol
; 41(35): 5388-5399, 2023 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37713657